AUTM Technology Valuation Course

AUTM Annual Meeting 25

Technology Valuation and the Financial Side of Licensing

Sunday, March 2 
7:30 a.m. – 4 p.m. 

AUTM’s Technology Valuation Course teaches the fundamental principles of how to construct the various financial terms that go into a license. The course examines concepts such as valuation versus pricing and risk, as well as a series of valuation methodologies, including cost, income, industry standards (comparables), rules of thumb, discounted cash flow and equity. The first segment concludes with a review of payment structures within a license and shows the financial flows under a typical academic-stage life sciences license. 

The course goes on to focus on practical applications including case studies. The class is divided into groups to develop license term proposals for the discussion of two technologies. 

If you have, or will have, responsibility for negotiating licenses, or would like to learn more about the process, the Licensing Valuation Course is ideal. Attendees should have a basic familiarity with the structure and payment mechanisms used in a license and be proficient in web searching and Excel spreadsheets. 

 Instructors

As a prerequisite to the course, attendees will have access to the Technology Valuation Four-Part webinar series, a $325 value, and be expected to watch these videos before the start of the course. 



Annual Meeting Sponsors

Wellspring
AstraZeneca
Amster, Rothstein & Ebenstein LLP
KPPB
Osage University Partners
PhRMA
Owkin
TreMonti
Casimir Jones
Nixon Peabody
Parker Highlander
Dennemeyer
NIIMBL
DRI Healthcare
Scorpius BioManufacturing
Marshall Gerstein
Rose Rock Bridge
BlankRome
TEDCO
Fox Rothschild LLP
Novartis
Quarles
RocketSmart
Tradespace
Conley Rose
NYU Langone Health
Smart & Big
CSL Innovation Pty Ltd
NovusGC, Professional Law Corporation
Royalty Pharma
Computer Packages
Isaacson, Miller
McCoy Russell LLP
Berggren Oy
Gardner Search
Hoffmann & Baron, LLP
Nexsen Pruet, PLLC
Merck
Wave
Riverside